Apexigen America

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Apexigen America sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials none currently recruiting 3 completed early-phase tilt upper quartile by trial count

Apexigen America: 3 sponsored US clinical trials, none currently recruiting.

Apexigen America sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is MSI-H, with 1 trials.

Upper-quartile sponsor footprint

Apexigen America sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

3 total, page 1 of 1

COMPLETED Phase 2

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

NCT03165994
COMPLETED Phase 1

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

NCT03123783
COMPLETED Phase 1

Study of the CD40 Agonistic Monoclonal Antibody APX005M

NCT02482168

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1

Therapeutic Areas

MSI-H 1
NSCLC 1
Melanoma 1
Urothelial Carcinoma 1
Head and Neck Cancer 1
Cancer 1

How the Apexigen America early-phase archive is shaped

3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).

Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: MSI-H (1 trial), 5 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Apexigen America: archived-pipeline peers nationwide

Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Apexigen America sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Apexigen America10xBio22nd Century GroupAA SecordAAADRS Clinical Research Center23andMe3-C Institute for Social Development3 Waves Wellness3EO Health
Apexigen America sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Apexigen America sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Apexigen America page

3 registered trials is a research-attention snapshot, not an endorsement of Apexigen America or any single study.

  • None of Apexigen America's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • MSI-H is the condition Apexigen America studies most, compare against other sponsors active in the same condition before evaluating a specific study. See MSI-H trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Apexigen America pipeline card: 3 registered trials from official public datasets.Report a data error.